Kids R Golden 6” Campaign organized by Future Society for Youth aimed at educating people about cancer among children, launched its first platform at BBK Health Center, Al Hidd, in cooperation with Health Promotion Directorate.

Through this platform, volunteers highlighted childhood cancer symptoms, treatment and coping mechanisms to raise awareness of the disease in the community.

Chairman"...

Solasia Pharma K.K. (TSE:4597, Headquarters: Tokyo, President & CEO: Yoshihiro Arai, hereinafter “Solasia”), a specialty pharmaceutical company based in Asia, today announced that patient registration reached the target number of cases for the darinaparsin Phase 2 study.

The Phase 2 study is being conducted as a multinational, multicentre, single-arm, open-label, non-randomized study to evaluate the efficacy and safety of darinaparsin"...

In line with the UAE’s aim of providing leading healthcare services, Consultant Orthopaedic Surgeon Dr Herve Ouanezar uses his expertise in knee surgery and sports medicine to treat athletes at Emirates Hospital Day Surgery and Medical Center, Motorcity and EMIRATES SPORTSMED – a leading sports and human performance clinic in Dubai.

In the past five years, there has been considerable progress in anterior cruciate ligament (ACL) reconstruction,"...

The National Health Regulatory Authority, an independent regulatory body providing provision of healthcare in Bahrain is holding its ‘First Bahrain Health Regulatory Conference’ 2019 to be held for three days on the 28th to 30th of November 2019 at the Gulf Convention Centre, Manama.

The conference is being organized by Education Plus and Promed in collaboration with PowerUp and Perfect Solutions Advertising, with the support of government"...

The “Smile” initiative of the Future Youth Association, which provides psychosocial support to children with cancer in the Kingdom, organized a special celebration on the occasion of returning to schools with the great participation of the heroes’ kids, their parents and relatives. The event was organized with the support of INOVEST.

This celebration is part of the activities of the sixth edition of its awareness campaign “Our"...

Bahrain, Saturday 14 September 2019 – The Kingdom of Bahrain will host the first event of its kind in the region, the first Business Development Forum and Fair in healthcare sector (BDFEX), that will be held Under the patronage of President of the Supreme Council of Health, Lieutenant-General Dr Shaikh Mohamed bin Abdulla Al Khalifa, with a strategic partnership with Tamkeen, on October 23 and 24.

Member of the organizing committee of the"...

Under the patronage of His Excellency Lieutenant General Doctor Sheikh Mohamed Bin Abdullah, Chairman of the Supreme Council of Health, Bahrain will hold the first Business Development Forum and Fair in healthcare sector (BDFEX) on October 23 and 24, 2019.

Dr. Khalid Bumtaie, CEO of Proact International Consultancy, revealed that the BDFEX Forum provides an opportunity to introduce the latest national initiatives aimed at strengthening the health"...

The upcoming 1st Bahrain Emergency Medicine Conference (BEMC), organized by Bahrain Medical Society and held under the patronage of His Royal Highness Prime Minister Prince Khalifa bin Salman Al-Khalifa on October 9, will include five workshops and many important sessions run by local, regional and international experts and speakers in emergency medicine.

Dr. Salah Al-Ghanim, President of Bahrain Emergency Medicine Association and President of the"...

Polycystic Ovarian Syndrome (PCOS) is among the most common causes of infertility among women in the UAE. In order to address this issue, during the ‘PCOS Awareness Month’ in September, Fakih IVF is looking to reach out to all women by providing them with services that would educate them more on the subject.

PCOS is the most common endocrinopathy (hormonal disturbance) affecting reproductive aged women, with a prevalence of between 8"...

Samsung Bioepis Co., Ltd. today announced its expansion into the Brazilian biopharmaceutical market. The first product available in the country is BRENZYS™ (etanercept), a biosimilar referencing ENBREL®.i BRENZYS™ was approved by Agência Nacional de Vigilância Sanitária (ANVISA), the country’s health regulatory agency, in December 2017 for the treatment of rheumatoid arthritis, ankylosing spondylitis, plaque psoriasis, psoriatic arthritis, and non-radiographic axial spondyloarthritis.